cro.directory
← Compare landing

Cyagen Biosciences vs Cellentia, Inc.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCyagen BiosciencesCellentia, Inc.
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Translational Research
  • In Vitro Pharmacology
  • Biomarker Assays
  • Translational Research
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Cell Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Oncology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Santa Clara, California, United States
  • Headquarters, Mountain View, CA, USA
  • Headquarters, Mountain View, California, United States
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
Data not yet provided.

Find similar companies

Cyagen Biosciences alternatives · Cellentia, Inc. alternatives

Markdown mirror: /compare/apac-cyagen/cellentiabio.md